Provant Therapy System
Diathermy, Shortwave, For Use Other Than Applying Therapeutic Deep Heat. 510(k) K131979, from Regenesis Biomedical, Inc. (Scottsdale, AZ). Product code ILX, class 2.
As of Nov 21, 2026, K131979 is an FDA 510(k) held by Regenesis Biomedical, Inc., substantially equivalent on Dec 13, 2013 after 168 days, with no recalls tied to it in FDA's recall database.
- Review time: 168 days
- Recalls: 0
The Provant Therapy System is indicated for adjunctive use in the palliative treatment of postoperative pain and edema in superficial soft tissue.
- Provant System, Model 4201K091791 · Regenesis Biomedical, Inc. · Apr 7, 2010
- Active System; Avenue8K241395 · Caerus Corporation · Dec 18, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 28, 2013
- Review panel
- Physical Medicine
- Regulation
- 21 CFR 890.5290
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files